Japan News
-
US FDA's Priority Review Status for Takeda's IND
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013
Singapore: Takeda Pharmaceutical and its wholly-owned subsidiary, Takeda Pharmaceuticals USA, have announced that the US...Read more
-
India invites Japanese firms to invest in healthcare
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2013
New Delhi: Aiming at becoming one of the global manufacturing hubs, besides being a large healthcare market, India has i...Read more
-
BS Survey: Healthcare is getting smarter in Asia
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Nov, 2012
...Read more
-
Japan's top 5 bio firms fund $100 mn HIV, TB research
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 May, 2013
Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come toge...Read more
-
Eisai gets WHO prequalification, will donate 2.2 bn doses
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...Read more
-
BSA-CMR Survey: APAC CROs stick to an average of 50 clients
Japan | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Sysmex wins performance award in the US
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2012
Singapore: The wholly-owned US subsidiary of Sysmex, Sysmex America, has won the seventh annual Pinnacle Award presented...Read more
-
Solasia appoints Yoshihiro Arai as president
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013
Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to...Read more
-
New medtech market infographic published
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2013
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...Read more
-
Thomson Reuters to restore Tohoku to pre-earthquake state
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2013
Singapore: The intellectual property and science business of Thomson Reuters has collaborated with Japan's Tohoku Univer...Read more
-
Proteus, Otsuka to collaborate on new medicines
Japan | News | By BioSpectrum Bureau | 0 Comment | 06 Jul, 2012
Singapore: Proteus Digital Health and Otsuka Pharmaceutical, a subsidiary of Japan-headquartered Otsuka Group, have ente...Read more
-
Lonza, BioWa sign research agreements with Pfizer
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko ...Read more
-
FDA recommends Takeda's drug for Chrohn's disease
Japan | Regulatory | By BioSpectrum Bureau | 1 Comment | 24 Apr, 2014
Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committ...Read more
-
Harlan Japan appoints Hiroharu Okochi as president
Japan | Influencers | By BioSpectrum Bureau | 2 Comment | 10 Dec, 2013
Singapore: Harlan Contract Research Services (CRS), a division of Harlan Laboratories, a privately held provider of gene...Read more
-
Accuray to expand services in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2012
Singapore: Accuray, a radiation oncology company, has extended its industry-leading Emerald Service Program for the Tomo...Read more
-
What services do APAC CROs offer to their clients?
Japan | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Shionogi partners with six Irish universities
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...Read more
-
Why big pharma is busy acquiring injectables firms?
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013
Big pharma companies are gearing up to combat the shortage of injectables in the US through acquiring companies with app...Read more
